Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04543461 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

American Lung Association (ALA) Lung Health Cohort

StatusRecruiting
PhaseNot specified
Started2021-10-29
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Sep 2026 → Jun 30, 2027
See other at-risk trials from Johns Hopkins University

Amendment history

2026-09-24
Primary completion pushed: 2026-09 → 2027-06-30
Completion pushed: 2026-09 → 2027-06-30
2026-02-02
Study Status, Contacts/Locations v45
Study sitesdetails revised at 8 of 37 sites
2026-01-20
Study Status, Contacts/Locations v44
Study sitesdetails revised at 3 of 37 sites
2025-03-25
Study Status, Contacts/Locations v43
Study sitescontacts updated at 6 of 37 sites
2024-11-07
Study Status, Contacts/Locations v42
Study sitesdetails revised at 3 of 37 sites
Show 41 earlier versions
2024-06-14
Study Status, Contacts/Locations v41
Study sitesdetails revised at 8 of 37 sites
2024-05-09
Study Status v40
Primary completion date2024-05→2026-09
Completion date2024-05→2026-09
2024-01-10
Study Status, Contacts/Locations v39
Study sitesdetails revised at 1 of 37 sites
2023-10-10
Study Status, Contacts/Locations v38
Study sitesdetails revised at 1 of 37 sites
2023-09-28
Study Status, Contacts/Locations v37
Study sitesdetails revised at 3 of 37 sites
2023-09-22
Study Status, Contacts/Locations v36
Study sitesdetails revised at 2 of 37 sites
2023-04-18
Study Status, Contacts/Locations v35
Study sitesdetails revised at 1 of 37 sites
2022-12-14
Study Status, Contacts/Locations v34
Study sitesdetails revised at 1 of 37 sites
2022-11-15
Study Status, Contacts/Locations v33
Study sitesdetails revised at 3 of 37 sites
2022-11-09
Study Status, Contacts/Locations v32
Study sitescontacts updated at 1 of 37 sites
2022-10-31
Study Status, Contacts/Locations v31
Study sitescontacts updated at 1 of 37 sites
2022-09-08
Study Status, Contacts/Locations v30
Study sitesdetails revised at 1 of 37 sites
2022-08-30
Study Status, Contacts/Locations v29
Study sitesdetails revised at 2 of 37 sites
2022-07-27
Study Status, Contacts/Locations v28
Study sitesdetails revised at 1 of 37 sites
2022-06-23
Study Status, Contacts/Locations v27
Study sitesdetails revised at 3 of 37 sites
2022-05-27
Study Status, Study Description v26
Study description+240 characters
[...] anges in lung health over time, i.e., at 5 years and beyond. Recruitment of participants will be conducted by the participating study sites along with national and regional efforts from the American Lung Association. Recruitment efforts will be supported by the study web site www.lung.org/lung-study
2022-05-26
Study Status, Contacts/Locations v25
Study sitesdetails revised at 2 of 37 sites
2022-04-28
Study Status, Contacts/Locations v24
Study sitescontacts updated at 32 of 37 sites
2022-04-26
Study Status, Contacts/Locations v23
Study sitescontacts updated at 1 of 37 sites
2022-03-07
Study Status, Contacts/Locations v22
Study sitesdetails revised at 6 of 37 sites
2022-02-04
Study Status, Contacts/Locations v21
Study sitesdetails revised at 1 of 37 sites
2022-02-02
Study Status, Contacts/Locations v20
Study sitesdetails revised at 1 of 37 sites
2022-01-28
Study Status, Contacts/Locations v19
Study sitesdetails revised at 3 of 37 sites
2022-01-05
Study Status, Contacts/Locations v18
Study sitesdetails revised at 10 of 37 sites
2022-01-04
Study Status, Contacts/Locations v17
Study sitesdetails revised at 13 of 37 sites
2021-12-03
Study Status, Contacts/Locations v16
Study sitesdetails revised at 1 of 37 sites
2021-12-01
Study Status, Contacts/Locations v15
Study sitesdetails revised at 1 of 37 sites
2021-10-28
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v14
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2021-10→confirmed 2021-10-29
Study sitesdetails revised at 37 of 37 sites
2021-10-08
Study Status, Contacts/Locations v13
Study sites0→37
2021-09-22
Study Status v12
Start date2021-09→2021-10
2021-08-18
Study Status v11
Start date2021-08→2021-09
2021-07-19
Study Status v10
Start date2021-07→2021-08
2021-06-10
Study Status v9
Start date2021-06→2021-07
2021-05-07
Study Status v8
Start date2021-05→2021-06
2021-04-12
Study Status v7
Start date2021-04→2021-05
2021-03-23
Study Status v6
Start date2021-03→2021-04
2021-02-10
Study Status v5
Start date2021-02→2021-03
2021-01-13
Study Status v4
Start date2021-01→2021-02
2020-12-09
Study Status, Eligibility v3
Start date2020-12→2021-01
Eligibility criteria+1,369 characters
Inclusion Criteria: 1- Age 25-35 years at the time of the baseline examination 2- Able to read and understand English or Spanish 3 -Has a social security number 4- Resident (citizen or non-citizen) of the United States (US) for at least 12 months prior to examination. Note: Individuals who are residents of the US who have temporarily spent time living outside of the US during the last 12 months (e.g., student exchange program, military posting) are eligible for participation. 5- Willing to provide contact information for at least 2 proxies who are likely to know [...] Exclusion Criteria: >Severe ast [...] [...]
2020-11-17
Study Status v2
Start date2020-11→2020-12
2020-10-14
Study Status v1
Start date2020-10→2020-11
2020-09-02
Original filing
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.
Trial Details
NCT Number NCT04543461
Lead Sponsor Johns Hopkins University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), American Lung Association, Stanford University
Conditions Lung Diseases
Enrollment 4,000 participants
Start Date 2021-10-29
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-23